Revol Ventures

A holdco for AI-native vertical software. Self-funded. Permanent.

Revol Ventures is structured as a holding company, not a fund. We build or acquire, operate, and hold, compounding cash flow across a portfolio of home-based care and behavioral health software companies, funded by a profitable engineering business.

How we make money, and how you do.

Holdco model

Equity sits on Revol Ventures's balance sheet. We hold permanently and compound. No fund cycle, no forced exits, no mark-up pressure.

Self-funded engine

TekRevol's cash flow funds the building. We don't raise to ship. That capital efficiency is the core underwriting advantage.

Build + buy arbitrage

We originate and build AI-native companies. We also acquire small cash-generating businesses at service multiples and transform them at software margins.

The AI-services wave is your window, and we're already inside it.

For two decades, the labor-intensive back office of regulated industries was un-investable. The unit economics never resolved into software margins. That window just closed.

AI can now run the workflows that required cheap labor, claims, eligibility, documentation, follow-up, at software margins, with software-like scaling. The category that emerges is services-as-software, and the companies that win will be the ones operating, not the ones selling tools to operators.

$102B

U.S. RCM market, 2024.

Fragmented

No clear vertical winner. Operator-led consolidation underway.

Compounding

Each added company makes the next cheaper to build and easier to sell.

One vertical. Three layers. Expanding wallet share.

ClaimShield, CareOS, and CensusFlow share the same agency customer. Each new layer adds revenue without new customer acquisition, and makes the others more valuable.

Layer 01
ClaimShield | Billing & RCM
First wedge into the agency. Sells on denial recovery.
Layer 02
CareOS | Operations
Same buyer. Cheaper to sell. Richer data.
Layer 03
CensusFlow | Analytics
Closes the loop. Turns operating data into the next decision.

Patient capital is our natural partner.

We're building for family offices and investors who understand the compounding math. If that's you, we'd like to talk.